To understand further the relevance of the interplay between XRCC1 and ALDH2 expression in cancer, we investigated whether the profile we observed in most cancers (i.e., low ALDH2 and high XRCC1 mRNA levels, Fig. 2) affects patient prognosis. The gene discussed is XRCC1; the disease is cancer.